As of August 28, 2026, Genmab A/S (GNMSF) has a DilutionWatch DilutionScore of 12/100, rated LOW dilution risk. Genmab A/S has a market capitalization of $15.44B, 61.39M shares outstanding, 4 institutional holders tracked.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for GNMSF.
Market Data
Market Cap$15.44B
Shares Outstanding61.39M
Float60.64M
Cash$1.52B
Debt$5.35B
Short InterestN/A
Institutional Holdings
QoQ: ↓ 84.6% shares (2026Q1 vs prior)
4 institutional holders · 809.7K shares
#1
BARCLAYS PLC
711.9K shares
#2
MORGAN STANLEY
88.2K shares
#3
Marex Group plc
9.5K shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest199.1K
Days to Cover32.6
% of Float0.3%
FINRA data as of Jul 31, 2026
Recent SEC Activity
No recent SEC insights
Recent News
No recent news
Track GNMSF Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking GNMSF — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required